Early administration of tPA within a 6-h window for ischemic pathology involving the anterior circulation of the brain and within a 12-h window for lesions of the posterior circulation is proven to be a rapid and effective framework that significantly reduces morbidity and mortality in stroke patients [8]. This evidence concerns the gene PLAT and Stroke.